Search

Janice C. Hallmark

Examiner (ID: 18843)

Most Active Art Unit
2918
Art Unit(s)
2973, 2925, 2915, 2918
Total Applications
1734
Issued Applications
1710
Pending Applications
4
Abandoned Applications
27

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18281905 [patent_doc_number] => 20230097377 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-30 [patent_title] => Biodegradable Implant Including Naltrexone [patent_app_type] => utility [patent_app_number] => 17/711910 [patent_app_country] => US [patent_app_date] => 2022-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12873 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17711910 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/711910
Biodegradable implant including naltrexone Mar 31, 2022 Issued
Array ( [id] => 17836295 [patent_doc_number] => 20220273600 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-01 [patent_title] => LITHIUM SALTS OF N-SUBSTITUTED GLYCINE COMPOUNDS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/699892 [patent_app_country] => US [patent_app_date] => 2022-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13636 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17699892 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/699892
LITHIUM SALTS OF N-SUBSTITUTED GLYCINE COMPOUNDS AND USES THEREOF Mar 20, 2022 Abandoned
Array ( [id] => 19140519 [patent_doc_number] => 20240139310 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-02 [patent_title] => MICROPARTICLE COMPOSITIONS AND METHODS USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/279459 [patent_app_country] => US [patent_app_date] => 2022-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10864 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18279459 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/279459
MICROPARTICLE COMPOSITIONS AND METHODS USE THEREOF Mar 8, 2022 Pending
Array ( [id] => 19140332 [patent_doc_number] => 20240139108 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-02 [patent_title] => ORAL PHARMACEUTICAL COMPOSITION OF ARSENIC TRIOXIDE [patent_app_type] => utility [patent_app_number] => 18/547260 [patent_app_country] => US [patent_app_date] => 2022-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5160 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18547260 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/547260
ORAL PHARMACEUTICAL COMPOSITION OF ARSENIC TRIOXIDE Feb 24, 2022 Pending
Array ( [id] => 19691229 [patent_doc_number] => 20250009774 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-09 [patent_title] => COMPOSITIONS AND METHODS USING A COMBINATION OF OLEUROPEIN AND MAGNESIUM [patent_app_type] => utility [patent_app_number] => 18/547934 [patent_app_country] => US [patent_app_date] => 2022-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7677 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18547934 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/547934
COMPOSITIONS AND METHODS USING A COMBINATION OF OLEUROPEIN AND MAGNESIUM Feb 22, 2022 Pending
Array ( [id] => 17640694 [patent_doc_number] => 20220168432 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-02 [patent_title] => MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES [patent_app_type] => utility [patent_app_number] => 17/675842 [patent_app_country] => US [patent_app_date] => 2022-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19112 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17675842 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/675842
MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES Feb 17, 2022 Abandoned
Array ( [id] => 17836363 [patent_doc_number] => 20220273668 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-01 [patent_title] => IRAK4 DEGRADERS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/651201 [patent_app_country] => US [patent_app_date] => 2022-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22291 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17651201 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/651201
IRAK4 degraders and uses thereof Feb 14, 2022 Issued
Array ( [id] => 17895345 [patent_doc_number] => 20220305007 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-29 [patent_title] => INJECTABLE FORMULATION [patent_app_type] => utility [patent_app_number] => 17/650822 [patent_app_country] => US [patent_app_date] => 2022-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16343 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17650822 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/650822
INJECTABLE FORMULATION Feb 10, 2022 Abandoned
Array ( [id] => 18351014 [patent_doc_number] => 20230139125 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-04 [patent_title] => DIETARY SUPPLEMENT FOR IMPROVING BRAIN PERFORMANCE [patent_app_type] => utility [patent_app_number] => 17/912371 [patent_app_country] => US [patent_app_date] => 2022-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8016 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17912371 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/912371
DIETARY SUPPLEMENT FOR IMPROVING BRAIN PERFORMANCE Feb 2, 2022 Abandoned
Array ( [id] => 17609816 [patent_doc_number] => 20220152095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-19 [patent_title] => ELECTROLYTE COMPOSITION AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 17/587463 [patent_app_country] => US [patent_app_date] => 2022-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4309 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17587463 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/587463
ELECTROLYTE COMPOSITION AND METHODS OF USE Jan 27, 2022 Pending
Array ( [id] => 19372955 [patent_doc_number] => 12064494 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-08-20 [patent_title] => Methods, compositions, and delivery systems for therapeutic skin treatments [patent_app_type] => utility [patent_app_number] => 17/586214 [patent_app_country] => US [patent_app_date] => 2022-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5967 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17586214 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/586214
Methods, compositions, and delivery systems for therapeutic skin treatments Jan 26, 2022 Issued
Array ( [id] => 17733319 [patent_doc_number] => 20220218778 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-14 [patent_title] => COMPOSITION FOR REDUCING BODY FAT COMPRISING GREEN TEA EXTRACT CONTAINING GALLOCATECHIN GALLATE AS AN ACTIVE INGREDIENT AND MANUFACTURING METHOD THEREOF [patent_app_type] => utility [patent_app_number] => 17/570765 [patent_app_country] => US [patent_app_date] => 2022-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12391 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17570765 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/570765
Composition for reducing body fat comprising green tea extract containing gallocatechin gallate as an active ingredient and manufacturing method thereof Jan 6, 2022 Issued
Array ( [id] => 18970285 [patent_doc_number] => 20240050377 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-15 [patent_title] => ORAL SOLID CANNABINOID OIL COMPOSITION FOR TREATING CENTRAL NERVOUS SYSTEM DISORDERS [patent_app_type] => utility [patent_app_number] => 18/260276 [patent_app_country] => US [patent_app_date] => 2021-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5440 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18260276 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/260276
ORAL SOLID CANNABINOID OIL COMPOSITION FOR TREATING CENTRAL NERVOUS SYSTEM DISORDERS Dec 22, 2021 Pending
Array ( [id] => 19001986 [patent_doc_number] => 20240066057 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-29 [patent_title] => METHOD FOR TREATING PAIN USING VANADIUM COMPOUNDS [patent_app_type] => utility [patent_app_number] => 18/258518 [patent_app_country] => US [patent_app_date] => 2021-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11734 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18258518 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/258518
METHOD FOR TREATING PAIN USING VANADIUM COMPOUNDS Dec 19, 2021 Pending
Array ( [id] => 18762874 [patent_doc_number] => 11813253 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-11-14 [patent_title] => Composition and method for proton pump inhibitor suspension [patent_app_type] => utility [patent_app_number] => 17/554737 [patent_app_country] => US [patent_app_date] => 2021-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9316 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17554737 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/554737
Composition and method for proton pump inhibitor suspension Dec 16, 2021 Issued
Array ( [id] => 18503562 [patent_doc_number] => 11701352 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-07-18 [patent_title] => Process for preparing aripiprazole oral soluble film [patent_app_type] => utility [patent_app_number] => 17/552333 [patent_app_country] => US [patent_app_date] => 2021-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5788 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17552333 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/552333
Process for preparing aripiprazole oral soluble film Dec 14, 2021 Issued
Array ( [id] => 17702721 [patent_doc_number] => 20220202727 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-30 [patent_title] => HYDROGEL COMPOSITIONS COMPRISING ENCAPSULATED CELLS AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/546489 [patent_app_country] => US [patent_app_date] => 2021-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29809 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17546489 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/546489
HYDROGEL COMPOSITIONS COMPRISING ENCAPSULATED CELLS AND METHODS OF USE THEREOF Dec 8, 2021 Abandoned
Array ( [id] => 17625624 [patent_doc_number] => 20220160639 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-26 [patent_title] => MAZINDOL IR/SR MULTILAYER TABLET AND ITS USE FOR THE TREATMENT OF ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD) [patent_app_type] => utility [patent_app_number] => 17/538333 [patent_app_country] => US [patent_app_date] => 2021-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6828 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17538333 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/538333
MAZINDOL IR/SR MULTILAYER TABLET AND ITS USE FOR THE TREATMENT OF ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD) Nov 29, 2021 Abandoned
Array ( [id] => 18163506 [patent_doc_number] => 20230030099 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-02 [patent_title] => PHARMACEUTICAL COMPOSITION COMPRISING MARMELO EXTRACT FOR PREVENTING OR TREATING OBESITY [patent_app_type] => utility [patent_app_number] => 17/535815 [patent_app_country] => US [patent_app_date] => 2021-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11673 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17535815 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/535815
PHARMACEUTICAL COMPOSITION COMPRISING MARMELO EXTRACT FOR PREVENTING OR TREATING OBESITY Nov 25, 2021 Abandoned
Array ( [id] => 17625613 [patent_doc_number] => 20220160628 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-26 [patent_title] => PROCESS FOR MANUFACTURING IMPROVED SEMI-SOFT SOLID DOSAGE FORMS AND SOFT CHEWS PRODUCED THEREBY [patent_app_type] => utility [patent_app_number] => 17/534947 [patent_app_country] => US [patent_app_date] => 2021-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3349 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17534947 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/534947
PROCESS FOR MANUFACTURING IMPROVED SEMI-SOFT SOLID DOSAGE FORMS AND SOFT CHEWS PRODUCED THEREBY Nov 23, 2021 Pending
Menu